TPWA
TEVA icon

Twin Peaks Wealth Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Twin Peaks Wealth Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.93K Buy
+230
New +$7.4K ﹤0.01% 1250
2025
Q3 		– Sell
-24
Closed -$398 – 1915
2025
Q2 		$398 Buy
+24
New +$387 ﹤0.01% 1951

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Twin Peaks Wealth Advisors's TEVA Position: Q1 2026 in Review

Twin Peaks Wealth Advisors opened a new position in Teva Pharmaceuticals (TEVA) in Q1 2026: 230 shares worth $6.93K. The stake represents ﹤0.01% of the portfolio and ranks #1250 among its holdings. This is a return to the name: Twin Peaks Wealth Advisors previously reported a position in TEVA as recently as Q2 2025.

Twin Peaks Wealth Advisors first reported a position in TEVA in Q2 2025 and has held it in 2 quarters since. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Twin Peaks Wealth Advisors held 230 shares of Teva Pharmaceuticals worth $6.93K as of Q1 2026.
  • Teva Pharmaceuticals was a new Twin Peaks Wealth Advisors position in Q1 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of Twin Peaks Wealth Advisors's portfolio in Q1 2026, its #1250 holding.
  • Twin Peaks Wealth Advisors first reported a position in Teva Pharmaceuticals in Q2 2025 and has held it in 2 quarters since.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q1 2026, filed 8 May 2026.